Tuberous Sclerosis

  • Omar PachaEmail author
  • Adelaide Hebert


Tuberous sclerosis or tuberous sclerosis complex (TSC) is a genetic disorder that classically causes skin changes, intellectual disability, and seizures. This relatively common condition often involves the face with angiofibromas (adenoma sebaceum) that in the earliest stages may be misinterpreted as acne lesions. Variable expressivity complicates the diagnosis and epidemiology of this autosomal dominant disorder. Current treatment focuses on mechanical removal of the angiofibromas. Recently, topical or systemic IL-2 inhibitors like rapamycin have also shown promise as a therapy [1].


Intellectual Disability mTOR Inhibitor Tuberous Sclerosis Tuberous Sclerosis Complex mTOR Pathway 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hofbauer GFL, Marcollo-Pini A, Corsenca A, et al. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol. 2008;159:473–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991; 615:125–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Sancak O, Nellist M, Goedbloed M, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype–phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet. 2005;13:731–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Morrison PJ. Tuberous sclerosis: epidemiology, genetics and progress towards treatment. Neuroepidemiology. 2009;33:342–3.PubMedCrossRefGoogle Scholar
  5. 5.
    OSBORNE JP, FRYER A, WEBB D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125–7. doi: 10.1111/j.1749-6632.1991.tb37754.x.PubMedCrossRefGoogle Scholar
  6. 6.
    Weiner DM, Ewalt DH, Roach ES, Hensle TW. The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg. 1998;187:548–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex. J Child Neurol. 2004; 19:643.PubMedGoogle Scholar
  8. 8.
    Józwiak S, Schwartz RA, Janniger CK, Michałowicz R, Chmielik J. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37:911–7. doi: 10.1046/j.1365-4362.1998.00495.x.PubMedCrossRefGoogle Scholar
  9. 9.
    Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Sand M, Sand D, Thrandorf C, Paech V, Altmeyer P, Bechara FG. Review Cutaneous lesions of the nose 2010. Head Face Med. 2010;6:7.PubMedCrossRefGoogle Scholar
  11. 11.
    Swaroop MR, Nischal KC, Rajesh Gowda CM, Umashankar NU, Basavaraj HB, Sathyanarayana BD. Radiofrequency ablation of adenoma sebaceum. J Cutan Aesthet Surg. 2008;1:89.CrossRefGoogle Scholar
  12. 12.
    Kaufman AJ, Grekin RC, Geisse JK, Frieden IJ. Treatment of adenoma sebaceum with the copper vapor laser. J Am Acad Dermatol. 1995;33:770–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Salido R, Garnacho-Saucedo G, Cuevas-Asencio I, Ruano J, Galán-Gutierrez M, Vélez A, Moreno-Giménez J. Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis—associated facial angiofibroma. J Eur Acad Dermatol Venereol. 2011. doi: 10.1111/j.1468-3083.2011.04212.x.PubMedGoogle Scholar
  14. 14.
    Kaufman ME, Curtis AR, Fleischer AB. Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin. J Dermatol Treat. 2012;23(1):46–8.CrossRefGoogle Scholar
  15. 15.
    Guba M, Von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8:128–35.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of DermatologyUniversity of Texas Health Science Center, HoustonHoustonUSA

Personalised recommendations